Global Solid Tumor Drug Market Professional Survey Report 2017

September 2017 | 119 pages | ID: GBC41F4AE27EN
QYResearch

Abstracts

This report studies Solid Tumor Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• AstraZeneca
• Biogen
• Baxter
• Celgene Corporation
• Abbott Laboratories
• Pfizer Inc
• Amgen Limited & Amgen Ireland Limited
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc.
• F. Hoffmann-La Roche Ltd.
• Eli Lilly and Company
• Johnson & Johnson

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Small Molecules
• Biologics

By Application, the market can be split into

• Oncology
• Neurology
• Radiology
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Solid Tumor Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF SOLID TUMOR DRUG

1.1 Definition and Specifications of Solid Tumor Drug
  1.1.1 Definition of Solid Tumor Drug
  1.1.2 Specifications of Solid Tumor Drug
1.2 Classification of Solid Tumor Drug
  1.2.1 Small Molecules
  1.2.2 Biologics
1.3 Applications of Solid Tumor Drug
  1.3.1 Oncology
  1.3.2 Neurology
  1.3.3 Radiology
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF SOLID TUMOR DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Solid Tumor Drug
2.3 Manufacturing Process Analysis of Solid Tumor Drug
2.4 Industry Chain Structure of Solid Tumor Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF SOLID TUMOR DRUG

3.1 Capacity and Commercial Production Date of Global Solid Tumor Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Solid Tumor Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Solid Tumor Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Solid Tumor Drug Major Manufacturers in 2016

4 GLOBAL SOLID TUMOR DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Solid Tumor Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Solid Tumor Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Solid Tumor Drug Sales and Growth Rate Analysis
  4.3.2 2016 Solid Tumor Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Solid Tumor Drug Sales Price
  4.4.2 2016 Solid Tumor Drug Sales Price Analysis (Company Segment)

5 SOLID TUMOR DRUG REGIONAL MARKET ANALYSIS

5.1 North America Solid Tumor Drug Market Analysis
  5.1.1 North America Solid Tumor Drug Market Overview
  5.1.2 North America 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Solid Tumor Drug Sales Price Analysis
  5.1.4 North America 2016 Solid Tumor Drug Market Share Analysis
5.2 China Solid Tumor Drug Market Analysis
  5.2.1 China Solid Tumor Drug Market Overview
  5.2.2 China 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Solid Tumor Drug Sales Price Analysis
  5.2.4 China 2016 Solid Tumor Drug Market Share Analysis
5.3 Europe Solid Tumor Drug Market Analysis
  5.3.1 Europe Solid Tumor Drug Market Overview
  5.3.2 Europe 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Solid Tumor Drug Sales Price Analysis
  5.3.4 Europe 2016 Solid Tumor Drug Market Share Analysis
5.4 Southeast Asia Solid Tumor Drug Market Analysis
  5.4.1 Southeast Asia Solid Tumor Drug Market Overview
  5.4.2 Southeast Asia 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Solid Tumor Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Solid Tumor Drug Market Share Analysis
5.5 Japan Solid Tumor Drug Market Analysis
  5.5.1 Japan Solid Tumor Drug Market Overview
  5.5.2 Japan 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Solid Tumor Drug Sales Price Analysis
  5.5.4 Japan 2016 Solid Tumor Drug Market Share Analysis
5.6 India Solid Tumor Drug Market Analysis
  5.6.1 India Solid Tumor Drug Market Overview
  5.6.2 India 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Solid Tumor Drug Sales Price Analysis
  5.6.4 India 2016 Solid Tumor Drug Market Share Analysis

6 GLOBAL 2012-2017E SOLID TUMOR DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Solid Tumor Drug Sales by Type
6.2 Different Types of Solid Tumor Drug Product Interview Price Analysis
6.3 Different Types of Solid Tumor Drug Product Driving Factors Analysis
  6.3.1 Small Molecules of Solid Tumor Drug Growth Driving Factor Analysis
  6.3.2 Biologics of Solid Tumor Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017E SOLID TUMOR DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Solid Tumor Drug Consumption by Application
7.2 Different Application of Solid Tumor Drug Product Interview Price Analysis
7.3 Different Application of Solid Tumor Drug Product Driving Factors Analysis
  7.3.1 Oncology of Solid Tumor Drug Growth Driving Factor Analysis
  7.3.2 Neurology of Solid Tumor Drug Growth Driving Factor Analysis
  7.3.3 Radiology of Solid Tumor Drug Growth Driving Factor Analysis
  7.3.4 Others of Solid Tumor Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF SOLID TUMOR DRUG

8.1 AstraZeneca
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 AstraZeneca 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 AstraZeneca 2016 Solid Tumor Drug Business Region Distribution Analysis
8.2 Biogen
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Biogen 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Biogen 2016 Solid Tumor Drug Business Region Distribution Analysis
8.3 Baxter
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Baxter 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Baxter 2016 Solid Tumor Drug Business Region Distribution Analysis
8.4 Celgene Corporation
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Celgene Corporation 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Celgene Corporation 2016 Solid Tumor Drug Business Region Distribution Analysis
8.5 Abbott Laboratories
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Abbott Laboratories 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Abbott Laboratories 2016 Solid Tumor Drug Business Region Distribution Analysis
8.6 Pfizer Inc
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Pfizer Inc 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Pfizer Inc 2016 Solid Tumor Drug Business Region Distribution Analysis
8.7 Amgen Limited & Amgen Ireland Limited
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Amgen Limited & Amgen Ireland Limited 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Amgen Limited & Amgen Ireland Limited 2016 Solid Tumor Drug Business Region Distribution Analysis
8.8 Bristol-Myers Squibb Company
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Bristol-Myers Squibb Company 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Bristol-Myers Squibb Company 2016 Solid Tumor Drug Business Region Distribution Analysis
8.9 GlaxoSmithKline plc.
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 GlaxoSmithKline plc. 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 GlaxoSmithKline plc. 2016 Solid Tumor Drug Business Region Distribution Analysis
8.10 F. Hoffmann-La Roche Ltd.
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 F. Hoffmann-La Roche Ltd. 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 F. Hoffmann-La Roche Ltd. 2016 Solid Tumor Drug Business Region Distribution Analysis
8.11 Eli Lilly and Company
8.12 Johnson & Johnson

9 DEVELOPMENT TREND OF ANALYSIS OF SOLID TUMOR DRUG MARKET

9.1 Global Solid Tumor Drug Market Trend Analysis
  9.1.1 Global 2017-2022 Solid Tumor Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Solid Tumor Drug Sales Price Forecast
9.2 Solid Tumor Drug Regional Market Trend
  9.2.1 North America 2017-2022 Solid Tumor Drug Consumption Forecast
  9.2.2 China 2017-2022 Solid Tumor Drug Consumption Forecast
  9.2.3 Europe 2017-2022 Solid Tumor Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Solid Tumor Drug Consumption Forecast
  9.2.5 Japan 2017-2022 Solid Tumor Drug Consumption Forecast
  9.2.6 India 2017-2022 Solid Tumor Drug Consumption Forecast
9.3 Solid Tumor Drug Market Trend (Product Type)
9.4 Solid Tumor Drug Market Trend (Application)

10 SOLID TUMOR DRUG MARKETING TYPE ANALYSIS

10.1 Solid Tumor Drug Regional Marketing Type Analysis
10.2 Solid Tumor Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Solid Tumor Drug by Region
10.4 Solid Tumor Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF SOLID TUMOR DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL SOLID TUMOR DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Solid Tumor Drug
Table Product Specifications of Solid Tumor Drug
Table Classification of Solid Tumor Drug
Figure Global Production Market Share of Solid Tumor Drug by Type in 2016
Figure Small Molecules Picture
Table Major Manufacturers of Small Molecules
Figure Biologics Picture
Table Major Manufacturers of Biologics
Table Applications of Solid Tumor Drug
Figure Global Consumption Volume Market Share of Solid Tumor Drug by Application in 2016
Figure Oncology Examples
Table Major Consumers in Oncology
Figure Neurology Examples
Table Major Consumers in Neurology
Figure Radiology Examples
Table Major Consumers in Radiology
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Solid Tumor Drug by Regions
Figure North America Solid Tumor Drug Market Size (Million USD) (2012-2022)
Figure China Solid Tumor Drug Market Size (Million USD) (2012-2022)
Figure Europe Solid Tumor Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Solid Tumor Drug Market Size (Million USD) (2012-2022)
Figure Japan Solid Tumor Drug Market Size (Million USD) (2012-2022)
Figure India Solid Tumor Drug Market Size (Million USD) (2012-2022)
Table Solid Tumor Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Solid Tumor Drug in 2016
Figure Manufacturing Process Analysis of Solid Tumor Drug
Figure Industry Chain Structure of Solid Tumor Drug
Table Capacity and Commercial Production Date of Global Solid Tumor Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Solid Tumor Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Solid Tumor Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Solid Tumor Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Solid Tumor Drug 2012-2017
Figure Global 2012-2017E Solid Tumor Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Solid Tumor Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Solid Tumor Drug Capacity and Growth Rate
Table 2016 Global Solid Tumor Drug Capacity (MT) List (Company Segment)
Table 2012-2017E Global Solid Tumor Drug Sales (MT) and Growth Rate
Table 2016 Global Solid Tumor Drug Sales (MT) List (Company Segment)
Table 2012-2017E Global Solid Tumor Drug Sales Price (USD/Kg)
Table 2016 Global Solid Tumor Drug Sales Price (USD/Kg) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (MT) of Solid Tumor Drug 2012-2017E
Figure North America 2012-2017E Solid Tumor Drug Sales Price (USD/Kg)
Figure North America 2016 Solid Tumor Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (MT) of Solid Tumor Drug 2012-2017E
Figure China 2012-2017E Solid Tumor Drug Sales Price (USD/Kg)
Figure China 2016 Solid Tumor Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (MT) of Solid Tumor Drug 2012-2017E
Figure Europe 2012-2017E Solid Tumor Drug Sales Price (USD/Kg)
Figure Europe 2016 Solid Tumor Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (MT) of Solid Tumor Drug 2012-2017E
Figure Southeast Asia 2012-2017E Solid Tumor Drug Sales Price (USD/Kg)
Figure Southeast Asia 2016 Solid Tumor Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (MT) of Solid Tumor Drug 2012-2017E
Figure Japan 2012-2017E Solid Tumor Drug Sales Price (USD/Kg)
Figure Japan 2016 Solid Tumor Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (MT) of Solid Tumor Drug 2012-2017E
Figure India 2012-2017E Solid Tumor Drug Sales Price (USD/Kg)
Figure India 2016 Solid Tumor Drug Sales Market Share
Table Global 2012-2017E Solid Tumor Drug Sales (MT) by Type
Table Different Types Solid Tumor Drug Product Interview Price
Table Global 2012-2017E Solid Tumor Drug Sales (MT) by Application
Table Different Application Solid Tumor Drug Product Interview Price
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Solid Tumor Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 AstraZeneca Solid Tumor Drug Business Region Distribution
Table Biogen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Biogen Solid Tumor Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 Biogen Solid Tumor Drug Business Region Distribution
Table Baxter Information List
Table Product A Overview
Table Product B Overview
Table 2015 Baxter Solid Tumor Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 Baxter Solid Tumor Drug Business Region Distribution
Table Celgene Corporation Information List
Table Product A Overview
Table Product B Overview
Table 2016 Celgene Corporation Solid Tumor Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 Celgene Corporation Solid Tumor Drug Business Region Distribution
Table Abbott Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Laboratories Solid Tumor Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 Abbott Laboratories Solid Tumor Drug Business Region Distribution
Table Pfizer Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Inc Solid Tumor Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 Pfizer Inc Solid Tumor Drug Business Region Distribution
Table Amgen Limited & Amgen Ireland Limited Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Business Region Distribution
Table Bristol-Myers Squibb Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol-Myers Squibb Company Solid Tumor Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 Bristol-Myers Squibb Company Solid Tumor Drug Business Region Distribution
Table GlaxoSmithKline plc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline plc. Solid Tumor Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 GlaxoSmithKline plc. Solid Tumor Drug Business Region Distribution
Table F. Hoffmann-La Roche Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2016 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Business Region Distribution
Table Eli Lilly and Company Information List
Table Johnson & Johnson Information List
Figure Global 2017-2022 Solid Tumor Drug Market Size (MT) and Growth Rate Forecast
Figure Global 2017-2022 Solid Tumor Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Solid Tumor Drug Sales Price (USD/Kg) Forecast
Figure North America 2017-2022 Solid Tumor Drug Consumption Volume (MT) and Growth Rate Forecast
Figure China 2017-2022 Solid Tumor Drug Consumption Volume (MT) and Growth Rate Forecast
Figure Europe 2017-2022 Solid Tumor Drug Consumption Volume (MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Solid Tumor Drug Consumption Volume (MT) and Growth Rate Forecast
Figure Japan 2017-2022 Solid Tumor Drug Consumption Volume (MT) and Growth Rate Forecast
Figure India 2017-2022 Solid Tumor Drug Consumption Volume (MT) and Growth Rate Forecast
Table Global Sales Volume (MT) of Solid Tumor Drug by Type 2017-2022
Table Global Consumption Volume (MT) of Solid Tumor Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Solid Tumor Drug by Region